Kamada (KMDA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Kamada (KMDA) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA10.42 Million ≈ $27.92K USD) by net assets (ILA265.23 Million ≈ $711.08K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Kamada to measure how much of total assets are equity-financed.

Kamada - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Kamada's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Kamada to evaluate the quality of earnings relative to operating cash generation.

Kamada Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kamada ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Sidetrade
PA:ALBFR
0.086x
PC1 Group JSC
VN:PC1
0.169x
Shenzhen Longood Intelligent Electric Co Ltd Class A
SHE:300543
0.031x
Monarch Networth Capital Limited
NSE:MONARCH
0.001x
Tianjin Motimo Membrane Tech
SHE:300334
-0.028x
Zhejiang Xinchai Co. Ltd.
SHE:301032
N/A
Castro
TA:CAST
-0.018x
Yibin Paper Industry Co Ltd
SHG:600793
0.088x

Annual Cash Flow Conversion Efficiency for Kamada (2007–2024)

The table below shows the annual cash flow conversion efficiency of Kamada from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see KMDA market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA259.46 Million
≈ $695.61K
ILA47.59 Million
≈ $127.60K
0.183x +937.34%
2023-12-31 ILA244.02 Million
≈ $654.21K
ILA4.32 Million
≈ $11.57K
0.018x -89.11%
2022-12-31 ILA176.02 Million
≈ $471.90K
ILA28.59 Million
≈ $76.64K
0.162x +425.62%
2021-12-31 ILA176.82 Million
≈ $474.06K
ILA-8.82 Million
≈ $-23.64K
-0.050x -146.63%
2020-12-31 ILA178.64 Million
≈ $478.92K
ILA19.11 Million
≈ $51.22K
0.107x -47.51%
2019-12-31 ILA135.32 Million
≈ $362.79K
ILA27.57 Million
≈ $73.92K
0.204x +117.11%
2018-12-31 ILA112.38 Million
≈ $301.28K
ILA10.55 Million
≈ $28.27K
0.094x +115.90%
2017-12-31 ILA89.49 Million
≈ $239.92K
ILA3.89 Million
≈ $10.43K
0.043x +52.93%
2016-12-31 ILA66.74 Million
≈ $178.94K
ILA1.90 Million
≈ $5.09K
0.028x +114.74%
2015-12-31 ILA72.51 Million
≈ $194.39K
ILA-13.98 Million
≈ $-37.48K
-0.193x -57.44%
2014-12-31 ILA80.99 Million
≈ $217.14K
ILA-9.92 Million
≈ $-26.59K
-0.122x -185.86%
2013-12-31 ILA89.97 Million
≈ $241.21K
ILA-3.85 Million
≈ $-10.33K
-0.043x +85.28%
2012-12-31 ILA28.39 Million
≈ $76.12K
ILA-8.26 Million
≈ $-22.15K
-0.291x -801.65%
2011-12-31 ILA22.67 Million
≈ $60.79K
ILA940.36K
≈ $2.52K
0.041x -89.67%
2010-12-31 ILA26.49 Million
≈ $71.01K
ILA10.63 Million
≈ $28.50K
0.401x +192.43%
2009-12-31 ILA30.15 Million
≈ $80.83K
ILA-13.09 Million
≈ $-35.10K
-0.434x +56.84%
2008-12-31 ILA12.64 Million
≈ $33.89K
ILA-12.72 Million
≈ $-34.11K
-1.006x -456.76%
2007-12-31 ILA69.57 Million
≈ $186.51K
ILA-12.57 Million
≈ $-33.71K
-0.181x --

About Kamada

TA:KMDA Israel Drug Manufacturers - Specialty & Generic
Market Cap
$334.18 Million
ILA124.65 Billion ILA
Market Cap Rank
#14139 Global
#161 in Israel
Share Price
ILA2161.00
Change (1 day)
-0.05%
52-Week Range
ILA2099.00 - ILA2870.00
All Time High
ILA3940.00
About

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmuniza… Read more